Krebs Biochemicals (India) Market Value
| KREBSBIO | 94.25 1.25 1.34% |
| Symbol | Krebs |
Krebs Biochemicals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Krebs Biochemicals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Krebs Biochemicals.
| 01/28/2023 |
| 01/17/2025 |
If you would invest 0.00 in Krebs Biochemicals on January 28, 2023 and sell it all today you would earn a total of 0.00 from holding Krebs Biochemicals and or generate 0.0% return on investment in Krebs Biochemicals over 720 days. Krebs Biochemicals is related to or competes with GPT Healthcare, Apollo Hospitals, Healthcare Global, Entero Healthcare, Fortis Healthcare, Landmark Cars, and Country Club. Krebs Biochemicals is entity of India. It is traded as Stock on NSE exchange. More
Krebs Biochemicals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Krebs Biochemicals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Krebs Biochemicals and upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.48 | |||
| Information Ratio | 0.0618 | |||
| Maximum Drawdown | 29.86 | |||
| Value At Risk | (4.96) | |||
| Potential Upside | 7.3 |
Krebs Biochemicals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Krebs Biochemicals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Krebs Biochemicals' standard deviation. In reality, there are many statistical measures that can use Krebs Biochemicals historical prices to predict the future Krebs Biochemicals' volatility.| Risk Adjusted Performance | 0.061 | |||
| Jensen Alpha | 0.3022 | |||
| Total Risk Alpha | 0.3166 | |||
| Sortino Ratio | 0.0861 | |||
| Treynor Ratio | 0.1766 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Krebs Biochemicals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Krebs Biochemicals and Backtested Returns
Krebs Biochemicals appears to be very steady, given 3 months investment horizon. Krebs Biochemicals and has Sharpe Ratio of 0.0683, which conveys that the firm had a 0.0683% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Krebs Biochemicals, which you can use to evaluate the volatility of the firm. Please exercise Krebs Biochemicals' Downside Deviation of 3.48, mean deviation of 3.24, and Risk Adjusted Performance of 0.061 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Krebs Biochemicals holds a performance score of 5. The company secures a Beta (Market Risk) of 1.68, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Krebs Biochemicals will likely underperform. Please check Krebs Biochemicals' value at risk, and the relationship between the jensen alpha and skewness , to make a quick decision on whether Krebs Biochemicals' current price movements will revert.
Auto-correlation | 0.23 |
Weak predictability
Krebs Biochemicals and has weak predictability. Overlapping area represents the amount of predictability between Krebs Biochemicals time series from 28th of January 2023 to 23rd of January 2024 and 23rd of January 2024 to 17th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Krebs Biochemicals and price movement. The serial correlation of 0.23 indicates that over 23.0% of current Krebs Biochemicals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.23 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 153.66 |
Krebs Biochemicals and lagged returns against current returns
Autocorrelation, which is Krebs Biochemicals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Krebs Biochemicals' stock expected returns. We can calculate the autocorrelation of Krebs Biochemicals returns to help us make a trade decision. For example, suppose you find that Krebs Biochemicals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Krebs Biochemicals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Krebs Biochemicals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Krebs Biochemicals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Krebs Biochemicals stock over time.
Current vs Lagged Prices |
| Timeline |
Krebs Biochemicals Lagged Returns
When evaluating Krebs Biochemicals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Krebs Biochemicals stock have on its future price. Krebs Biochemicals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Krebs Biochemicals autocorrelation shows the relationship between Krebs Biochemicals stock current value and its past values and can show if there is a momentum factor associated with investing in Krebs Biochemicals and.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.